These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 21228137)

  • 41. Mucosal immune responses to capsular pneumococcal polysaccharides in immunized preschool children and controls with similar nasal pneumococcal colonization rates.
    Zhang Q; Arnaoutakis K; Murdoch C; Lakshman R; Race G; Burkinshaw R; Finn A
    Pediatr Infect Dis J; 2004 Apr; 23(4):307-13. PubMed ID: 15071283
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle.
    Kozlowski PA; Williams SB; Lynch RM; Flanigan TP; Patterson RR; Cu-Uvin S; Neutra MR
    J Immunol; 2002 Jul; 169(1):566-74. PubMed ID: 12077289
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucosal antibody response induced with a nasal virosome-based influenza vaccine.
    Durrer P; Glück U; Spyr C; Lang AB; Zurbriggen R; Herzog C; Glück R
    Vaccine; 2003 Oct; 21(27-30):4328-34. PubMed ID: 14505915
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mucosal immune responses and protection against tetanus toxin after intranasal immunization with recombinant Lactobacillus plantarum.
    Grangette C; Müller-Alouf H; Goudercourt D; Geoffroy MC; Turneer M; Mercenier A
    Infect Immun; 2001 Mar; 69(3):1547-53. PubMed ID: 11179325
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Induction of systemic and mucosal immunity and maintenance of its memory against influenza A virus by nasal vaccination using a new mucosal adjuvant SF-10 derived from pulmonary surfactant in young cynomolgus monkeys.
    Mizuno D; Kimoto T; Sakai S; Takahashi E; Kim H; Kido H
    Vaccine; 2016 Apr; 34(16):1881-8. PubMed ID: 26954466
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of mucosal lining fluid sampling methods and influenza-specific IgA detection assays for use in human studies of influenza immunity.
    de Silva TI; Gould V; Mohammed NI; Cope A; Meijer A; Zutt I; Reimerink J; Kampmann B; Hoschler K; Zambon M; Tregoning JS
    J Immunol Methods; 2017 Oct; 449():1-6. PubMed ID: 28647455
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pre-existing influenza-specific nasal IgA or nasal viral infection does not affect live attenuated influenza vaccine immunogenicity in children.
    Cole ME; Kundu R; Abdulla AF; Andrews N; Hoschler K; Southern J; Jackson D; Miller E; Zambon M; Turner PJ; Tregoning JS
    Clin Exp Immunol; 2021 Apr; 204(1):125-133. PubMed ID: 33314126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Oral Bacteria Combined with an Intranasal Vaccine Protect from Influenza A Virus and SARS-CoV-2 Infection.
    Nagai M; Moriyama M; Ichinohe T
    mBio; 2021 Aug; 12(4):e0159821. PubMed ID: 34399617
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Measles vaccination of infants in a well-vaccinated population.
    Carson MM; Spady DW; Albrecht P; Beeler JA; Thipphawong J; Barreto L; Grimsrud KM; Pabst HF
    Pediatr Infect Dis J; 1995 Jan; 14(1):17-22. PubMed ID: 7715983
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Oral immunization with
    Shrivastava S; Agnememel AB; Ndungo E; Islam D; Liang Y; Frenck RW; Pasetti MF
    mSphere; 2024 Jan; 9(1):e0041923. PubMed ID: 38132716
    [No Abstract]   [Full Text] [Related]  

  • 51. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
    Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
    Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of measles immunity among infants in Maputo City, Mozambique.
    Jani JV; Holm-Hansen C; Mussá T; Zango A; Manhiça I; Bjune G; Jani IV
    BMC Public Health; 2008 Nov; 8():386. PubMed ID: 19014485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine.
    Greenbaum E; Engelhard D; Levy R; Schlezinger M; Morag A; Zakay-Rones Z
    Vaccine; 2004 Jun; 22(20):2566-77. PubMed ID: 15193382
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified pulmonary surfactant is a potent adjuvant that stimulates the mucosal IgA production in response to the influenza virus antigen.
    Mizuno D; Ide-Kurihara M; Ichinomiya T; Kubo I; Kido H
    J Immunol; 2006 Jan; 176(2):1122-30. PubMed ID: 16394001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reduced secretory antibody response to live attenuated measles and poliovirus vaccines in malnourished children.
    Chandra RK
    Br Med J; 1975 Jun; 2(5971):583-5. PubMed ID: 1131622
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.
    Bergquist C; Johansson EL; Lagergård T; Holmgren J; Rudin A
    Infect Immun; 1997 Jul; 65(7):2676-84. PubMed ID: 9199436
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.
    Gallichan WS; Rosenthal KL
    Vaccine; 1995 Nov; 13(16):1589-95. PubMed ID: 8578847
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV mucosal vaccine: nasal immunization with gp160-encapsulated hemagglutinating virus of Japan-liposome induces antigen-specific CTLs and neutralizing antibody responses.
    Sakaue G; Hiroi T; Nakagawa Y; Someya K; Iwatani K; Sawa Y; Takahashi H; Honda M; Kunisawa J; Kiyono H
    J Immunol; 2003 Jan; 170(1):495-502. PubMed ID: 12496436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a measles vaccine campaign in Ethiopia using oral-fluid antibody surveys.
    Nigatu W; Samuel D; Cohen B; Cumberland P; Lemma E; Brown DW; Nokes J
    Vaccine; 2008 Sep; 26(37):4769-74. PubMed ID: 18644417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Detection of systemic and mucosal HPV-specific IgG and IgA antibodies in adolescent girls one and two years after HPV vaccination.
    Scherpenisse M; Mollers M; Schepp RM; Meijer CJ; de Melker HE; Berbers GA; van der Klis FR
    Hum Vaccin Immunother; 2013 Feb; 9(2):314-21. PubMed ID: 23149693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.